CE for Nurses

Partners in Pancreatic Cancer (PPC) CE for Nurses section contains a collection of continuing educational activities focusing on ongoing evidence-based scientific data and resources for treating pancreatic cancer.

Need continuing nursing credits? Select a program below:

Evolving Treatment Options and the Compassionate Care of Patients with Advanced Pancreatic Cancer – This activity provides a practical guide to assist you in the development of compassionate treatment plans that address each patient’s potential treatment options, individual goals, QOL, and outcomes.

CE Expired, Courses Available for Information Only.
Shining Light on Pancreatic Cancer: Keeping You Up-to-Date and In the Know – This activity will provide a look at the clinical application of new and emerging therapeutic options for advanced metastatic pancreatic cancer, as well as examine steps we as nurses can take to assure a patient-centered approach to treatment.

Cases in Advanced Metastatic Pancreatic Cancer – Two cases of patients with advanced metastatic pancreatic cancer are explored which include how anatomy influences the clinical presentation of pancreatic cancer, initial diagnostic workup and staging, indications for surgical resection, and factors determining resectability. Appropriate combination regimens for frontline therapy, new formulations of existing drugs, and emerging treatment options are also discussed.

Making Sense of Emerging Therapies in Pancreatic Cancer: Are We Finally on the Right Track? – The vast majority of patients with pancreatic cancer present with disease which is either metastatic or locally advanced inoperable. At that point, systemic therapy becomes the mainstay of care. Over the past several years, the standard of care has been a gemcitabine-based regimen. Most recently, two positive phase 3 trial results have led to a shift in the way patients with advanced metastatic pancreatic cancer are treated. With additional ongoing trials and the promise of additional treatment options on the horizon, it is important to be educated about these emerging treatments.

Research, Advocacy and Practice: Working Together to Impact Outcomes in Pancreatic Cancer – This activity brings together experts in advocacy, research, and practice to share recent progress made in science and practice which are showing a positive impact to overall care and survival. With this information, nurses will be best prepared to assist in the challenging and sometimes painful life decisions faced by this patient population and their caregivers.

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved